Results 91 to 100 of about 39,654 (197)

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms [PDF]

, 2009
Francis Grand, Claire Hidalgo-Curtis, Thomas Ernst, Katerina Zoi, Christine Zoi, Carolann McGuire, Sebastian Kreil, Amy V. Jones, Joannah Score, Georgia Metzgeroth, David Oscier, Andrew G. Hall, Christian Brandts, Hubert Serve, Andreas Reiter, Andrew Chase, Nicholas C.P. Cross   +16 more
openalex   +1 more source

Patient-reported outcomes data from REVEAL at the time of enrollment (baseline): A prospective observational study of patients with polycythemia vera in the United States [PDF]

, 2018
Boccia, Ralph V, Colucci, Philomena, Grunwald, Michael R, Mesa, Ruben, Oh, Stephen T, Paranagama, Dilan, Parasuraman, Shreekant, Stein, Brady L   +7 more
core   +2 more sources

Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones [PDF]

, 2009
Philip Beer, Amy V. Jones, Anthony J. Bench, Andrea Goday‐Fernández, Elaine Boyd, Krishna J. Vaghela, Wendy N. Erber, Bassam Odeh, Christine L. Wright, Mary Frances McMullin, Jonathan Cullis, Brian J.P. Huntly, Claire Harrison, Nicholas C.P. Cross, Anthony R. Green   +14 more
openalex   +1 more source

The natural history and treatment outcome of blast phase BCR-ABL− myeloproliferative neoplasms

, 2008
Constantine S. Tam, Roberto M. Nussenzveig, Uday Popat, Carlos E. Bueso‐Ramos, Deborah A. Thomas, Jorgé E. Cortes, Richard E. Champlin, Stefan E. Ciurea, Taghi Manshouri, Sherry M. Pierce, Hagop M. Kantarjian, Srđan Verstovšek   +11 more
openalex   +1 more source

Phospho‐STAT5 and phospho‐Akt expression in chronic myeloproliferative neoplasms [PDF]

, 2009
Lizz Grimwade, Lisa Happerfield, Colin Tristram, Gary McIntosh, Mark Rees, Anthony J. Bench, Elaine Boyd, Marie C Hall, Amy Quinn, Nigel H. Piggott, Paul Scorer, Mike Scott, Wendy N. Erber   +12 more
openalex   +1 more source

Myelodysplastic/Myeloproliferative Neoplasms [PDF]

, 2009
Kathryn Foucar
openalex   +1 more source

Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms

, 2008
L Bernard, Claude Bélisle, Luigina Mollica, Sylvie Provost, D-C Roy, D. Gary Gilliland, Ross L. Levine, Lambert Busque   +7 more
openalex   +1 more source

Cytogenetic correlates of TET2 mutations in 199 patients with myeloproliferative neoplasms [PDF]

, 2009
Kebede Hussein, Omar Abdel‐Wahab, Terra L. Lasho, Daniel L. Van Dyke, Ross L. Levine, Curtis A. Hanson, Animesh Pardanani, Ayalew Tefferi   +7 more
openalex   +1 more source

JAK2V617F mediates resistance to DNA damage-induced apoptosis by modulating FOXO3A localization and Bcl-xL deamidation. [PDF]

, 2016
The JAK2V617F mutation is found in most patients with a myeloproliferative neoplasm (MPN). This gain-of-function mutation dysregulates cytokine signaling and is associated with increased accumulation of DNA damage, a process likely to drive disease ...
Ahn, JS, Chen, E, Green, AR, Kent, DG, Li, J, Park, HJ   +5 more
core  

Advances in Understanding and Management of Myeloproliferative Neoplasms

, 2009
A. M. Vannucchi, Paola Guglielmelli, Ayalew Tefferi   +2 more
openalex   +1 more source